Published in Cancer Weekly, August 14th, 2001
This clinical study, funded by BTG and organized by the U.K.'s Cancer Research Campaign, will take place at Leicester Royal Infirmary and Imperial Cancer Research Fund's unit at the Churchill Hospital, Oxford, United Kingdom. The study should provide a good foundation for further trials of the efficacy of AQ4N in a range of tumor types when given with radiotherapy or with cancer chemotherapeutics.
The main objectives of the trial are to establish the maximum...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.